Skip to main content
Log in

Polycythaemia vera und essenzielle Thrombozythämie

Differenzialdiagnostik und Management zweier seltener Erkrankungen

  • Fortbildung
  • Published:
Pädiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Barbui T et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018;8(2):15

  2. Cario H et al. Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol. 2009;88(8):713-9

  3. Cario H et al. Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera. Br J Haematol. 2008;142(4):622-6

  4. Ianotto JC et al. Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review. Haematologica. 2019;104(8):1580-8

  5. Putti MC et al. Essential thrombocythemia in children and adolescents. Cancers. 2021;13(23):6147

  6. Cario H et al. Erythrocytosis in children and adolescents-classification, characterization, and consensus recommendations for the diagnostic approach. Pediatr Blood Cancer. 2013;60(11):1734-8

  7. Tuschl K et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet. 2012;90(3):457-66

  8. Stockklausner C et al. Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management. Ann Hematol. 2021;100(7):1647-65

  9. Petrides PE et al. Onkopedia-Leitlinie essentielle Thrombozythaemie. www.onkopedia.com

  10. Lengfelder E et al. Onkopedia-Leitlinie Polycythaemia vera. www.onkopedia.com

  11. Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 Years. Ann Intern Med. 1995;123(9):656-64

  12. Rungjirajittranon T et al. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms. BMC cancer. 2019;19(1):184

  13. Kucine N et al. Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia. Pediatr Blood Cancer. 2021;68(3):e28888

  14. Stoops K, Kuril S. Ruxolitinib in a child with JAK2 exon 12 mutant polycythemia vera. J Ped Hematol Oncol. 2022; doi: 10.1097/MPH.0000000000002549

  15. Barbui T. How to manage children and young adults with myeloproliferative neoplasms. Leukemia. 2012;26(7):1452-7

  16. Aydogan T et al. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets. 2006;17(5):328-31

  17. Buss DH et al. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med. 1994;96(3):247-53

  18. Simanek R et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Hemost. 2010;8(1):114-20

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Holger Cario.

Ethics declarations

Der Autor war als Referent und Berater für Novartis, Chiesi, BMS/Celgene, BluebirdBio und Vertex tätig. Er erklärt, dass dies keinen Einfluss auf die Inhalte des Beitrags hatte.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cario, H. Polycythaemia vera und essenzielle Thrombozythämie. Pädiatrie 34, 44–49 (2022). https://doi.org/10.1007/s15014-022-4759-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15014-022-4759-9

Navigation